fenoterol

Small moleculeexperimental

Fenoterol is a β2-adrenergic receptor agonist and bronchodilator medication used in the treatment of asthma. — Wikipedia

Clinical trial activity

17 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
9
Phase 3
9
Phase 4
2

Earliest trial started Feb 1, 1990 (NCT02177370)

Timeline

1990s

  1. Jan 1, 1990

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

Cc1ccc2c(c1)Sc1ccc(C)cc1S2
Mol. weight
244.38 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1-(3,5-dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane
  • 1-(3,5-dihydroxyphenyl)-1-hydroxy-2-((4-hydroxyphenyl)isopropylamino)ethane
  • 1-(p-hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane
  • 1-(p-hydroxyphenyl)-2-((beta-hydroxy-beta-(3',5'-dihydroxyphenyl))ethyl)aminopropane
  • 3,5-dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol
  • 3,5-dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol
  • 5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol
  • 5-{1-hydroxy-2-[2-(4-hydroxy-phenyl)-1-methyl-ethylamino]-ethyl}-benzene-1,3-diol
  • berodual
  • berodual
  • berodual
  • berodual n
  • berotec
  • berotec
  • berotec
  • berotec 100
  • berotec 200
  • berotec [as hydrobromide]
  • bronchodual
  • duovent
  • duovent
  • duovent
  • fenoterol
  • fenoterol
  • fenoterol
  • fenoterol
  • fenoterol
  • fenoterol
  • fenoterol
  • fenoterol
  • fenoterol
  • fenoterol hcl
  • fenoterol hydrobromide
  • fenoterol hydrobromide
  • fenoterol hydrobromide
  • fenoterol hydrochloride
  • fenoterol - ipratropium
  • fenoterol, ipratropium drug combination
  • fenoterolum
  • fenoterolum
  • iprafen
  • phenoterol
  • phenoterol
  • phenoterol
  • th-1165a [as hydrobromide salt]
  • th-1165a [as hydrobromide salt]

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05294965Early Phase 1 (Phase 1)Apr 27, 2022University of Basel
NCT05183841N/AMar 31, 2022University of Sao Paulo
NCT03910985Phase 4Apr 23, 2019CHU Mont-Godinne
NCT03031093N/AJun 1, 2017Federal University of Pernambuco, Universidade Federal do Rio Grande do Norte
NCT01933984N/AAug 1, 2013Changhua Christian Hospital
NCT02054299Phase 1Apr 1, 2013University of Goettingen
NCT01440335Phase 1Jul 10, 2011National Institute on Aging (NIA)
NCT01095016Phase 3Mar 1, 2010Chang Gung University, Otsuka
NCT00460577Phase 4Mar 1, 2007Novartis
NCT02176187Phase 3Apr 1, 2003Boehringer Ingelheim
NCT02176200Phase 3Apr 1, 2003Boehringer Ingelheim
NCT00274066Phase 3Oct 1, 2002Boehringer Ingelheim
NCT02173795Phase 3Oct 1, 2002Boehringer Ingelheim
NCT02182505Phase 3Sep 1, 1998Boehringer Ingelheim
NCT02182479Phase 3Apr 1, 1998Boehringer Ingelheim
NCT02173782Phase 3Feb 1, 1998Boehringer Ingelheim
NCT02177370Phase 3Feb 1, 1990Boehringer Ingelheim
Showing 17 of 17 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Boehringer IngelheimFor profit8811990
Chang Gung UniversityAcademic/Hospital1012010
Changhua Christian HospitalAcademic/Hospital1112013
CHU Mont-GodinneAcademic/Hospital1112019
Federal University of PernambucoAcademic/Hospital1012017
National Institute on Aging (NIA)Government1112011
NovartisFor profit1112007
OtsukaFor profit1112010
Universidade Federal do Rio Grande do NorteAcademic/Hospital1112017
University of BaselAcademic/Hospital1112022
University of GoettingenAcademic/Hospital1112013
University of Sao PauloAcademic/Hospital1112022
12 organizations
Page 1 / 1